Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai
about
Antiretroviral therapy response among HIV-2 infected patients: a systematic reviewHIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes.Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance.HIV-2 Infection: Where Are We Today?Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.Unexpected diagnostic findings in some HIV positive individuals in Bangladesh.
P2860
Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@ast
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@en
type
label
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@ast
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@en
prefLabel
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@ast
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@en
P2093
P2860
P1476
Characteristics, immunological ...... infections (HIV 1/2) in Mumbai
@en
P2093
A D Harries
Deshpande Alaka
Joanna Ladomirska
Mansoor Homa
Montaldo Chiara
Varghese Bhanumati
Zachariah Rony
P2860
P304
P407
P577
2010-12-01T00:00:00Z